Prostate Cancer Screening Among Men With High Risk Genetic Predisposition
|2||Enrolling by invitation||
The Genetic Education for Men Trial: Web-Based Education vs. Standard Care
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
|4||Active, not recruiting||
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
† Study has passed its completion date and status has not been verified in more than two years.